Network members

You are here

Re-Evaluation of Systemic Early Neuromuscular Blockade and TransThoracic Ultrasound Assessment of the Diaphragm (ROSETTA)

Status: 
Stopped
Period: 
April 2021

Diaphragm thickness will be measured using ultrasound in a subset of ROSE patients to determine whether the rate and magnitude of decreases in diaphragm thickness are greater in patients receiving neuromuscular blocking agents as compared to the control group.